THE DEAL, AT A GLANCE
From the announcementYingjiexin
01Who is involvedBacked by a fund under CICC Capital, Zhuhai Science, Technology Industry Group, Keystone CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedYingjiexin raised Series B, announced 2026-11-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersYingjiexin's $30M Series B adds capital for the stated global scaling of drug-delivery devices.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Yingjiexin · Financing Record
Explore source-linked visual explanations for Yingjiexin. Unsupported claims are withheld while source review continues.
Record 15390 · Recorded date: 2026-11-05
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →